New antibiotic found right under our noses
Compound in human nostrils could hold key in fight against drug-resistant superbugs
Scientists have discovered a new class of antibiotics - by analysing the microscopic warfare taking place inside people's noses.
Researchers from the University of Tubingen, Germany, found that 30 per cent of people carry around the superbug responsible for MRSA, the Staphylococcus aureus microbe, in their noses.
However, those people whose nostrils contain a bacteria known as Staphylococcus lugdunensis produce a hitherto unknown compound that can fight off bug.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
What is most notable is that Staphylococcus aureus, which is highly resistant to antibiotics, has not become immune to the effects of the compound, which scientists have named lugdunin.
"S. aureus has been exposed to this compound in the human nose for thousands of years and never developed resistance," study author Andreas Peschel said.
The research, published in the journal Nature, analysed nasal swabs from 37 individuals.
"If I was a bacteria, I wouldn’t go to the nose," Peschel added. "There’s nothing - it’s simply salty liquid and a tiny amount of nutrients.
"If we can understand why [the bugs] are living there, we may find new ways to combat bad bacteria, eradicate the spread of infection and maybe even find new therapeutic concepts, because we are in desperate need for new antibiotics."
While the human body carries thousands of bacterial species, most antibiotics are derived from microbes in the soil. However, no new classes have been identified for decades while many bugs are becoming immune to existing treatments. The new research adds weight to the idea that the human body itself could offer up new possibilities in the fight against antibiotic resistance, says The Guardian.
The scientists say the genes for the new antibiotic could be inserted into harmless bacteria, which could then be introduced to humans. Alternatively, lugdunin itself could eventually be produced commercially.
Even if lugdunin itself proved not to be a safe treatment for human cells, the bacteria could possibly be adapted to fight MRSA, added Peschel.
Lugdunin also defeated other bacteria, including a bug that can cause meningitis and bronchitis and a bacteria causing inflammation of the heart, as well as urinary tract and bloodstream infections.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
-
'It may not be surprising that creative work is used without permission'
Instant Opinion Opinion, comment and editorials of the day
By Justin Klawans, The Week US Published
-
5 simple items to help make your airplane seat more comfortable
The Week Recommends Gel cushions and inflatable travel pillows make a world of difference
By Catherine Garcia, The Week US Published
-
How safe are cruise ships in storms?
The Explainer The vessels are always prepared
By Devika Rao, The Week US Published
-
Home Office worker accused of spiking mistress’s drink with abortion drug
Speed Read Darren Burke had failed to convince his girlfriend to terminate pregnancy
By The Week Staff Published
-
In hock to Moscow: exploring Germany’s woeful energy policy
Speed Read Don’t expect Berlin to wean itself off Russian gas any time soon
By The Week Staff Published
-
Were Covid restrictions dropped too soon?
Speed Read ‘Living with Covid’ is already proving problematic – just look at the travel chaos this week
By The Week Staff Last updated
-
Inclusive Britain: a new strategy for tackling racism in the UK
Speed Read Government has revealed action plan setting out 74 steps that ministers will take
By The Week Staff Published
-
Sandy Hook families vs. Remington: a small victory over the gunmakers
Speed Read Last week the families settled a lawsuit for $73m against the manufacturer
By The Week Staff Published
-
Farmers vs. walkers: the battle over ‘Britain’s green and pleasant land’
Speed Read Updated Countryside Code tells farmers: ‘be nice, say hello, share the space’
By The Week Staff Published
-
Motherhood: why are we putting it off?
Speed Read Stats show around 50% of women in England and Wales now don’t have children by 30
By The Week Staff Published
-
Anti-Semitism in America: a case of double standards?
Speed Read Officials were strikingly reluctant to link Texas synagogue attack to anti-Semitism
By The Week Staff Published